Zeo ScientifiX Announces Board and Officer Changes

Ticker: ZEOX · Form: 8-K · Filed: Apr 2, 2025 · CIK: 1557376

Sentiment: neutral

Topics: management-change, board-composition, officer-appointment

TL;DR

Zeo ScientifiX shakes up leadership, new board and officers appointed.

AI Summary

Zeo ScientifiX, Inc. announced on April 1, 2025, a change in its board of directors and the appointment of new officers. The company also reported on compensatory arrangements for its officers. This filing follows a period of name changes, with the company formerly known as Organicell Regenerative Medicine, Inc. before 2018.

Why It Matters

Changes in a company's leadership and board can signal shifts in strategy or operational focus, potentially impacting future performance and investor confidence.

Risk Assessment

Risk Level: medium — Changes in executive and board composition can introduce uncertainty regarding future strategy and execution.

Key Players & Entities

FAQ

What specific changes were made to the board of directors?

The filing indicates a departure of directors and the election of new directors, but the specific names and number of changes are not detailed in the provided text.

Who are the newly appointed officers of Zeo ScientifiX, Inc.?

The filing mentions the appointment of certain officers but does not list their names or specific positions in the provided text.

What are the details of the compensatory arrangements for the officers?

The filing states that information regarding compensatory arrangements of certain officers is included, but the specifics are not present in the provided text.

When was the company formerly known as Organicell Regenerative Medicine, Inc.?

The company was formerly known as Organicell Regenerative Medicine, Inc. prior to June 25, 2018.

What is the state of incorporation for Zeo ScientifiX, Inc.?

Zeo ScientifiX, Inc. is incorporated in Nevada.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 2, 2025 regarding Zeo ScientifiX, Inc. (ZEOX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing